Int J Pharm Pharm Sci, Vol 7, Issue 6, 426-428Short Communication


ANTIMICROBIAL ACTIVITY AND POTENCY OF CASSIA ABBREVIATA OLIV STEM BARK EXTRACTS

MWILA MULUBWA1, SHIV PRAKASH2

1University of Zambia, School of Medicine, Department of Pharmacy, P. o. box 50110, Lusaka, Zambia, 2University of Zambia, School of Natural Sciences, Department of Chemistry, P. o. box 32379, Lusaka, Zambia
Email: mwila.mulubwa@gmail.com

Received: 16 Mar 2015 Revised and Accepted: 02 May 2015


ABSTRACT

Objective: To evaluate the potential antimicrobial activity and relative potency of aqueous and organic extracts of Cassia abbreviata Oliv stem bark against clinical isolates of Neisseria gonorrhoeae (NG), Pseudomonas aeruginosa (PA), Klebsiella pneumoniae (KP) and Candida albicans (CA).

Methods: Six extracts of Cassia abbreviata Oliv stem bark were prepared as follows: Four extracts were prepared following Soxhlet extraction procedure using ethanol, water, trichloromethane (TCM) and dichloromethane (DCM)+ethanol (1:1) as solvents, respectively. Two extracts were prepared by soaking the powdered stem bark in ethanol and water, respectively, and subjected to mechanical shaking for 8 hours. Antimicrobial activities and minimum inhibitory concentrations (MIC) of extracts were evaluated in-vitro using agar well diffusion assay.

Results: All extracts except TCM were active against NG and PA with an average MIC of 78.8 µg/ml. The cold aqueous extract had a lowest MIC (46.88 µg/ml) against PA, whereas both hot and cold ethanol extracts had a lowest MIC of 46.88 µg/ml against NG. Only hot extracts (ethanol, DCM+ethanol and TCM) were active against KP with a lowest MIC of 46.88 µg/ml of TCM extract. Both extracts of cold ethanol and DCM+ethanol were active against CA with cold ethanol extract having a lower MIC of 93.75 µg/ml compared with DCM+ethanol.

Conclusion: There were variations in in-vitro antimicrobial activities (microbial growth inhibition) of Cassia abbreviata Oliv stem bark extracts which depended on the solvent used. Organic extracts were more potent against NG, PA, KP and CA compared with aqueous extracts.

Keywords: Cassia abbreviata, Potency, Antibacterial, Antifungal.


Infectious diseases are a challenge, especially in the developing countries [1]. Eighty percent of the population in Africa depend on traditional medicinal plants to meet primary health care needs. As an actual fact, the numbers of traditional practitioners exceed that of allopathic practitioners in sub-Saharan Africa by 100 to 1 [2].

The use of medicinal plants to manage different ailments is a common practice among rural and urban populations of Zambia. Furthermore, more than 60% of Zambian children with high fever are treated with herbal medicines at home [2, 3]. Cassia abbreviata Oliv is an indigenous plant found in mixed woodlands of Zambia [3, 4]. It is often prescribed by most traditional healers in the treatment of leprosy, syphilis and toothache by use of aqueous decoction prepared from roots or stem barks. The leaves are also smoked as a remedy for haematuria [3]. Traditional herbalists and diviners use a decoction of Cassia abbreviata Oliv to treat sexually transmitted infections clinically manifested as urethral discharge and swellings in the groin [5]. Cassia abbreviata Oliv was reported to have been used in the management of Candida infections by some traditional healers [6].

Traditionally, the decoction of Cassia abbreviata Oliv is prepared by soaking fresh or dry stem bark/roots in water "overnight" (at least 12 hours) or boiled for some time. Some bioactive phytochemical compounds may be more soluble in aqueous than in organic solvent or vice versa [7]. It is, therefore, possible that extracts of the same plant obtained using different solvents and methods can exhibit variations in the bioactivity and potency. Plant extracts of proven bioactivity and potency are the most desired in effective and successful treatment of bacterial and fungal infections. Studies that compare bioactivities of the same plant are scarce in the literature.

This study evaluated the potential antibacterial and antifungal activity of Cassia abbreviata Oliv stem bark extracts against known pathogenic organisms. Antibacterial activity was assessed against Neisseria gonorrhoeae (NG), Pseudomonas aeruginosa (PA) and Klebsiella pneumoniae (KP) whereas antifungal activity was assessed against Candida albicans (CA). Extracts of Cassia abbreviata Oliv stem bark were obtained using cold and hot aqueous and organic solvents. Relative potencies were compared among the bioactive extracts.

The plant parts of Cassia abbreviata Oliv (stem bark, branches and fruits) were collected from its natural habitat in the outskirts west of Lusaka in Zambia. The bark was separated from the wood using a knife and a clean brush was used to remove insects and foreign matter from the bark. A few branches with leaves and fruits were taken for botanical identification and classification at the University of Zambia, Department of Biological Sciences. Voucher of the plant specimen was deposited at the Herbarium of the University of Zambia.

The Cassia abbreviata Oliv barks were cut into small pieces, spread on white paper and left to dry in the shade for 21 days. Dried barks were ground and powdered using a domestic grinding machine (Retsch GmbH, Type SM1, German). The powdered bark was stored in an umber container.

Six extracts of powdered bark were prepared using different extracting solvents. The Soxhlet extraction procedure was performed to prepare four extracts using ethanol (95%), distilled water, trichloromethane (TCM) and a mixture of dichloromethane (DCM)+ethanol (1:1), respectively. Each extraction was carried out for 8 hours. The extract solution was evaporated to dryness at 40 °C under reduced pressure using a rotary evaporator (Buchi model No. RE120). The dry residue was collected and stored in an airtight container.

The cold ethanol extract was prepared by mixing powdered bark with ethanol in a conical flask and subjected to mechanical shaking for 8 hours. The contents were filtered on Whatman No.1 filter paper and the filtrate was evaporated at 40 °C using a rotary evaporator under reduced pressure. The dry residue was stored in an airtight container.

The cold aqueous extract was prepared using distilled water by following the cold ethanol extracts procedure. However, the filtrate was not evaporated but quantified by calculating the difference between the mass of 50 ml of the filtrate and mass of 50 ml of distilled water (50.09g–49.73g = 0.36g/50 ml). This was performed in order to reflect a procedure of how the extract is prepared traditionally in Zambia. The solution was stored in a refrigerator (2-8 °C).

The dry crude extracts obtained from Soxhlet extraction (ethanol, water, TCM, DCM+ethanol) and cold ethanol procedures were each reconstituted with dimethylsulphoxide to the concentration of 1500 µg/ml. The cold aqueous extract solution was diluted with distilled water to a concentration of 1500 µg/ml.

The clinical isolates of bacteria and fungi were obtained from the University Teaching Hospital Microbiology Laboratory in Lusaka. Agar well diffusion assays were performed on chocolate agar, Mueller-Hinton agar and blood agar for NG, PA and KP , respectively. On seven already prepared chocolate agar plates, pure isolates of NG were inoculated by streaking with a flame sterilized loop. The seven agar plates were each set up and marked A, B, C, D, E, F and P, respectively. Plate ‘A’ for ethanol extract, plate ‘B’ for water extract, plate ‘C’ for TCM extract, plate ‘D’ for DCM+ethanol extract, plate ‘E’ for cold ethanol extract, plate ‘F’ for cold water extract and plate ‘P’ for positive control, respectively. A well was made on each agar plate using a sterile borer. To each corresponding well, 0.1 ml of each extract at a concentration of 1500 µg/ml was added, whereas 0.1 ml (100 mg/ml) of Ceftriaxone was added to the well of the agar plate marked ‘P’ to act as the positive control. The same procedure was performed on Mueller-Hinton agar and blood agar for PAand KP, respectively. However, Ciprofloxacin (0.1 ml, 2 mg/ml) was used as the positive control.

The procedure for the antifungal assay of CA was performed similarly to the antibacterial assay. Fluconazole (0.1 ml, 2 mg/ml) was used as a positive control. All the agar plates were incubated for 24 hours at 37 °C. Clear zones of microbial growth inhibition were observed in comparison with positive controls and taken as indicators of antibacterial and antifungal activity [8].

The MIC was determined for each extract that was active against the micro-organisms. Each bioactive extract was reconstituted to1500 µg/ml and was serially diluted appropriately to six concentrations (750, 375, 187.5, 93.75, 46.88 and 23.44 µg/ml). NG was inoculated on seven chocolate agar plates marked C1, C2, C3, C4, C5, C6 and P. A well was made on each agar plate using a sterile borer. 0.1 ml of each diluted extract was added to the appropriate well of the agar plate. 0.1 ml of Ceftriaxone (100 mg/ml) was added to the well on agar plate marked ‘P’ as a positive control. A similar procedure was performed on PA, KP and CA with appropriate agar plates and positive controls. Agar plates were incubated for 24 hours at 37 °C. MIC was determined as the lowest concentration at which a clear zone of microbial growth inhibition was observed.

The plant was identified as Cassia abbreviata Oliv (Family: Fabaceae, Genus: Cassia, Species: Abbreviata, Author: Oliver). The yields of the extracts are shown in table 1. The results for bioactivities and MICs of extracts are presented in table 2 and 3, respectively.

Table 1: Yields of extracts

S. No. Solvent used Quantity of extracts (g) Physical state Powdered bark used (g) Percent yield (%)
1 Ethanol 13.09 Brown crystals 69 19
2 Water 7.21 Brown crystals 60 12
3 TCM 0.13 Light green crystals 40 0.325
4 DCM+ethanol 4.47 Light brown crystals 60 12.8
5 Cold ethanol 0.13 Light brown crystals 50 8.9
6 Cold water 148 ml (7.2 g/l) Brown liquid 50 2.13

The cold water extract was quantified in the liquid state.

Table 2: In-vitro antibacterial and antifungal activities of plant extracts

S. No. Test extract (1500 µg/ml) NG PA KP CA
1 Ethanol + + + -
2 Water + + - -
3 TCM - - + -
4 DCM+ethanol + + + +
5 Cold ethanol + + - +
6 Cold water + + - -
Ceftriaxone + NT NT NT
Ciprofloxacin NT + + NT
Fluconazole NT NT NT +

Note: (+)= active (clear zone of microbial growth inhibition observed),(-)=inactive (no clear zone of microbial growth inhibition observed),(NT) = not tested.

Table 3: MICs of bioactive plant extracts

S. No. Test extract MICs of extracts in µg/ml
NG PA KP CA
1 Ethanol 46.88 93.75 187.5 NT
2 Water 93.75 93.75 NT NT
3 TCM NT NT 46.88 NT
4 DCM+ethanol 93.75 93.75 93.75 187.5
5 Cold ethanol 46.88 93.75 NT 93.75
6 Cold water 93.75 46.88 NT NT
Ceftriaxone + NT NT NT
Ciprofloxacin NT + + NT
Fluconazole NT NT NT +

Note: (+)= Active (clear zone of microbial growth inhibition observed);(NT) = Not tested; Number of agar plates for NG, PA, KP and CA were 31, 31, 19 and 13, respectively.

The highest percentage yield of extracts was achieved when ethanol was used as the extracting solvent. However, using TCM as solvent achieved the lowest percentage yield. This indicated that the majority of compounds were mostly soluble in hot ethanol and least soluble in hot TCM amongst extracting solvents used.

In the current study, five extracts (water, ethanol, DCM+ethanol, cold ethanol and cold water) showed in-vitro antibacterial activity against NG and PA by bacterial growth inhibition. Furthermore, three extracts (ethanol, TCM and DCM+ethanol) were active against KP. Our results further support the use of the decoction of Cassia abbreviate Oliv traditionally to treat gonorrhoea [9]. Similarly, Cassia abbreviata Oliv extracts (water, methanol and acetone) were found active against some gram positive and negative bacteria with MIC value range of 500–5000 µg/ml[10]. In the literature [11], the extract obtained using acetone demonstrated antibacterial activity against PA and KP with each MIC value of 80 µg/ml. In this study, the MIC values of active extracts ranged between 46.88 µg/ml and 187.5 µg/ml for PA and KP.

The differences in the MIC values of active extracts could arise from variations in solubility of specific bioactive compounds in different extracting solvents. The lower the MIC value the better the activity of the extract against micro-organisms [12]. Some scholars suggest the plant extracts MIC value of 100 µg/ml or lower as significant [12]. In this study, the hot ethanol extract had MIC value above 100 µg/ml for KP. This implies that the hot ethanol extract of Cassia abbreviate Oliv may be inferior in treating KP infections compared with other extracts.

In this study, only cold ethanol and DCM+ethanol extracts were found to have in-vitro antifungal activity against CA with cold ethanol extract being more potent than DCM+ethanol extract (MIC = 93.75 and 187.5 µg/ml, respectively). In a study by Kolaczkowski et al. [13], ethylacetate extract demonstrated anti fungal activity against CA with MIC of 1200 µg/ml which was less potent than DCM+ethanol extract in the current study. Nevertheless, in another study by Hamza et al. [14], methanol extracts of root and stem bark were reported inactive against CA. Arguably, the method (maceration in 80% methanol) and duration (24 hours) of extraction that Hamza et al. [14]employed could have affected the potency of active compounds. In the current study, Soxhlet extraction method (95% ethanol) was performed and lasted for 8 hours. It was therefore deduced that the cold ethanol and DCM+ethanol extracts of Cassia abbreviata Oliv may be useful in the treatment of superficial Candida infections.

The aqueous and organic extracts Cassia abbreviata Oliv stem bark have varying demonstrable antibacterial and antifungal activity through microbial growth inhibition. Organic extracts demonstrated more potent in-vitro activity than aqueous extracts. The extracts can potentially be applied in the treatment of community-acquired PA or KP infections and gonorrhoea. The antifungal activity of organic extracts (cold ethanol and DCM+ethanol) can be utilised in the management of CA infections like oral thrush.

ACKNOWLEDGEMENT

The authors appreciate support from the University Teaching Hospital Microbiology Laboratory in Lusaka and University of Zambia, Department of Chemistry and Department of Pharmacy, respectively.

CONFLICT OF INTERESTS

Authors have declared no conflict of interest

REFERENCES

  1. Ndhlala AR, Amoo SO, Ncube B, Moyo M, Nair JJ, Van Staden J. In: Kuete V. editor. Antibacterial, Antifungal, and antiviral activities of african medicinal plants. Oxford: Elsevier; 2013. p. 621-59.
  2. World Health Organization-WHO. Traditional Medicine Strategy 2002-2005. Geneva: WHO; 2002.
  3. Fowler DG. Traditional Ila Plant remedies from Zambia. Kirkia 2002;18(1):35-48.
  4. Phiri PS. A checklist of Zambian vascular plants. Pretoria: Sabonet; 2005.
  5. Ndubani P, Höjer B. Traditional healers and the treatment of sexually transmitted illnesses in rural Zambia. J Ethnopharmacol 1999;67(1):15-25.
  6. Runyoro D, Ngassapa O, Matee M, Joseph C, Moshi M. Medicinal plants used by Tanzanian traditional healers in the management of Candida infections. J Ethnopharmacol 2006;106(2):158-65.
  7. Eloff JN. Which extractant should be used for the screening and isolation of antimicrobial components from plants? J Ethnopharmacol 1998;60(1):1-8.
  8. Izzo AA, di Carlo G, Biscardi D, de Fusso R, Mascolo N, Borrelli F, et al. Biological screening of Italian medicinal plants for antibacterial activity. Phytother Res 1995;9(4):281-6.
  9. Maroyi A. An ethnobotanical survey of medicinal plants used by the people in Nhema communal area, Zimbabwe. J Ethnopharmacol 2011;136(2):347-54.
  10. Kambizi L, Afolayan AJ. An ethnobotanical study of plants used for the treatment of sexually transmitted diseases (njovhera) in Guruve District, Zimbabwe. J Ethnopharmacol 2001;77(1):5-9.
  11. Shai L, Chauke M, Magano S, Mogale A, Eloff J. Antibacterial activity of sixteen plant species from Phalaborwa, Limpopo Province, South Africa. J Med Plants Res 2013;7(26):1899-906.
  12. Eloff JN. Quantification the bioactivity of plant extracts during screening and bioassay guided fractionation. Phytomedicine 2004;11(4):370-1.
  13. Kolaczkowski M, Kolaczkowska A, Środa K, Ramalhete C, Michalak K, Mulhovo S, et al. Substrates and modulators of the multidrug transporter Cdr1p of Candida albicans in antifungal extracts of medicinal plants. Mycoses 2010;53(4):305-10.
  14. Hamza OJ, van den Bout-van den Beukel, Carolien JP, Matee MI, Moshi MJ, Mikx FH, et al. Antifungal activity of some Tanzanian plants used traditionally for the treatment of fungal infections. J Ethnopharmacol 2006;108(1):124-32.